Qi Jiang, Ph.D. - Publications

Affiliations: 
2006 Iowa State University, Ames, IA, United States 
Area:
Statistics, Industrial Engineering, Biostatistics Biology

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Psioda MA, Xu J, Jiang Q, Ke C, Yang Z, Ibrahim JG. Bayesian adaptive basket trial design using model averaging. Biostatistics (Oxford, England). PMID 31107534 DOI: 10.1093/biostatistics/kxz014  0.32
2018 Ma H, Russek-Cohen E, Izem R, Marchenko OV, Jiang Q. Sources of Safety Data and Statistical Strategies for Design and Analysis: Transforming Data Into Evidence. Therapeutic Innovation & Regulatory Science. 52: 187-198. PMID 29714524 DOI: 10.1177/2168479018755085  0.56
2018 Zink RC, Marchenko O, Sanchez-Kam M, Ma H, Jiang Q. Sources of Safety Data and Statistical Strategies for Design and Analysis: Clinical Trials. Therapeutic Innovation & Regulatory Science. 52: 141-158. PMID 29714519 DOI: 10.1177/2168479017738980  0.56
2018 Marchenko O, Russek-Cohen E, Levenson M, Zink RC, Krukas-Hampel MR, Jiang Q. Sources of Safety Data and Statistical Strategies for Design and Analysis: Real World Insights. Therapeutic Innovation & Regulatory Science. 52: 170-186. PMID 29714518 DOI: 10.1177/2168479017739270  0.56
2016 Zhao H, Hobbs BP, Ma H, Jiang Q, Carlin BP. Combining Non-randomized and Randomized Data in Clinical Trials Using Commensurate Priors. Health Services & Outcomes Research Methodology. 16: 154-171. PMID 28458614 DOI: 10.1007/s10742-016-0155-7  0.56
2016 Zhao H, Hodges JS, Ma H, Jiang Q, Carlin BP. Hierarchical Bayesian approaches for detecting inconsistency in network meta-analysis. Statistics in Medicine. PMID 27037506 DOI: 10.1002/sim.6938  0.4
2016 Jiang CY, Ruan Y, Wang XH, Zhao W, Jiang Q, Jing YF, Han BM, Xia SJ, Zhao FJ. MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator. Molecular and Cellular Endocrinology. PMID 26940039 DOI: 10.1016/j.mce.2016.02.023  0.36
2016 Jiang CY, Gao Y, Wang XJ, Ruan Y, Bei XY, Wang XH, Jing YF, Zhao W, Jiang Q, Li J, Han BM, Xia SJ, Zhao FJ. Long non-coding RNA lnc-MX1-1 is associated with poor clinical features and promotes cellular proliferation and invasiveness in prostate cancer. Biochemical and Biophysical Research Communications. PMID 26797523 DOI: 10.1016/j.bbrc.2016.01.056  0.36
2015 Zhou Y, Ke C, Jiang Q, Shahin S, Snapinn S. Choosing Appropriate Metrics to Evaluate Adverse Events in Safety Evaluation. Therapeutic Innovation & Regulatory Science. 49: 398-404. PMID 30222396 DOI: 10.1177/2168479014565470  0.32
2015 Ma H, Ke C, Jiang Q, Snapinn S. Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical Trials. Therapeutic Innovation & Regulatory Science. 49: 957-965. PMID 30222385 DOI: 10.1177/2168479015587363  0.56
2015 Gao Y, Jiang CY, Mao SK, Cui D, Hao KY, Zhao W, Jiang Q, Ruan Y, Xia SJ, Han BM. Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy. Asian Journal of Andrology. PMID 26732103  0.36
2015 Li G, Nie X, Chen J, Jiang Q, An T, Wong PK, Zhang H, Zhao H, Yamashita H. Enhanced visible-light-driven photocatalytic inactivation of Escherichia coli using g-C3N4/TiO2 hybrid photocatalyst synthesized using a hydrothermal-calcination approach. Water Research. PMID 26084941 DOI: 10.1016/j.watres.2015.05.053  0.4
2015 Zeng D, Chen MH, Ibrahim JG, Wei R, Ding B, Ke C, Jiang Q. A counterfactual p-value approach for benefit-risk assessment in clinical trials. Journal of Biopharmaceutical Statistics. 25: 508-24. PMID 25723915 DOI: 10.1080/10543406.2014.921514  0.32
2015 Chuang-Stein C, Jiang Q, Marchenko O. Commentary: preserving confidentiality of interim data. Clinical Trials (London, England). 12: 18-20. PMID 25480540 DOI: 10.1177/1740774514562032  0.56
2014 Chen HR, Zhao FJ, Wang XH, Jiang Q, Zhang Q, Han BM, Lu J, Xia SJ. The role of urethral pressure profile on treating premature ejaculation by tamsulosin. Asian Journal of Andrology. 16: 792-3. PMID 24759591 DOI: 10.4103/1008-682X.129208  0.36
2013 Lu YY, Jiang B, Zhao FJ, Cui D, Jiang Q, Yu JJ, Li EH, Wang XH, Han BM, Xia SJ. Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression. Asian Journal of Andrology. 15: 672-8. PMID 23792338 DOI: 10.1038/aja.2013.45  0.36
2013 Jiang Q, Snapinn S. Pure and hybrid causal effects on variables associated with an incident event. Journal of Biopharmaceutical Statistics. 23: 719-29. PMID 23786519 DOI: 10.1080/10543406.2011.555030  0.32
2012 Ke C, Ding B, Jiang Q, Snapinn SM. The issue of multiplicity in noninferiority studies. Clinical Trials (London, England). 9: 730-5. PMID 22879575 DOI: 10.1177/1740774512455370  0.32
2012 Jiang Q, Xia SJ. Zonal differences in prostate diseases. Chinese Medical Journal. 125: 1523-8. PMID 22800815  0.36
2012 Jiang B, Li EH, Lu YY, Jiang Q, Cui D, Jing YF, Xia SJ. Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer. Urology. 80: 484.e9-15. PMID 22554590 DOI: 10.1016/j.urology.2012.02.046  0.36
2012 Wang J, Ke C, Jiang Q, Zhang C, Snapinn S. Predicting analysis time in event-driven clinical trials with event-reporting lag. Statistics in Medicine. 31: 801-11. PMID 22344853 DOI: 10.1002/sim.4506  0.32
2012 Xia SJ, Cui D, Jiang Q. An overview of prostate diseases and their characteristics specific to Asian men. Asian Journal of Andrology. 14: 458-64. PMID 22306914 DOI: 10.1038/aja.2010.137  0.36
2011 Snapinn S, Jiang Q. Indirect comparisons in the comparative efficacy and non-inferiority settings. Pharmaceutical Statistics. 10: 420-6. PMID 21956948 DOI: 10.1002/pst.509  0.32
2011 Jiang Q, Han BM, Zhao FJ, Hong Y, Xia SJ. The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones. Asian Journal of Andrology. 13: 798-805. PMID 21765438 DOI: 10.1038/aja.2011.22  0.36
2011 Wang XH, Zhao FJ, Han BM, Jiang Q, Wang YC, Wu JH, Tang YQ, Zhang YP, Xia SJ. Primary stromal cells isolated from human various histological/pathological prostate have different phenotypes and tumor promotion role. Chinese Medical Journal. 124: 1700-7. PMID 21740781  0.36
2011 Snapinn S, Jiang Q. On the clinical meaningfulness of a treatment's effect on a time-to-event variable. Statistics in Medicine. 30: 2341-8. PMID 21520457 DOI: 10.1002/sim.4256  0.32
2011 Wang YC, Han BM, Wang XH, Yu SQ, Jiang Q, Zhao FJ, Hong Y, Xia SJ. [Characterization of stromal cell cultures from the prostatic peripheral zone of men at different ages]. Zhonghua Nan Ke Xue = National Journal of Andrology. 17: 219-23. PMID 21485542  0.36
2011 Snapinn S, Jiang Q. Analysis of multiple endpoints in clinical trials: it's time for the designations of primary, secondary and tertiary to go. Pharmaceutical Statistics. 10: 1-2. PMID 20029938 DOI: 10.1002/pst.402  0.32
2008 Snapinn S, Jiang Q. Controlling the type 1 error rate in non-inferiority trials. Statistics in Medicine. 27: 371-81. PMID 17914715 DOI: 10.1002/sim.3072  0.32
2008 Snapinn S, Jiang Q. Preservation of effect and the regulatory approval of new treatments on the basis of non-inferiority trials. Statistics in Medicine. 27: 382-91. PMID 17914712 DOI: 10.1002/sim.3073  0.32
Show low-probability matches.